+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
POC Lipid Testing Market - Global Forecast 2026-2032- Product Image
POC Lipid Testing Market - Global Forecast 2026-2032- Product Image
Sale

POC Lipid Testing Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5889599
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The POC Lipid Testing Market is projected to reach USD 801.75 Million in 2026. It is expected to continue growing at a CAGR of 6.92%, reaching USD 1,199.62 Million by 2032.

Point-of-Care Lipid Testing: Executive Summary

Point-of-care (POC) lipid testing enables cholesterol and related lipid measurements outside centralized laboratories, supporting faster clinical decisions in primary care, pharmacies, screening programs, and community settings. The field is shaped by the need for earlier cardiovascular risk identification, convenient testing pathways, reliable analytical performance, and integration with preventive-care workflows. Adoption depends on clinical utility, regulatory compliance, reimbursement, operator training, and confidence that results are accurate enough to guide follow-up care.

From Laboratory Dependence to Distributed Cardiovascular Screening

The landscape is shifting from laboratory-only testing toward distributed models that place diagnostic capability closer to patients. Portable instruments, simplified sample handling, connectivity, and shorter turnaround times can support opportunistic screening and more efficient treatment discussions. However, decentralized testing does not remove the need for quality assurance: organizations must manage calibration, external quality assessment, infection control, data governance, confirmatory testing, and appropriate referral when results are abnormal or clinically inconsistent.

Artificial Intelligence Strengthens Interpretation and Workflow Coordination

Artificial intelligence can add value by identifying incomplete or inconsistent records, prioritizing people for screening, combining lipid results with other cardiovascular risk factors, and prompting guideline-aligned follow-up. It can also support remote oversight, quality-control monitoring, inventory management, and detection of operational anomalies. Its safe use requires representative validation, transparent decision logic, human review, cybersecurity safeguards, and clear separation between analytical measurement and clinical interpretation. AI should augment-not replace-professional judgment and confirmatory laboratory assessment when indicated.

Regional Insights: Uneven Access Creates Distinct Deployment Priorities

North America emphasizes chronic-disease management, interoperable records, pharmacy and primary-care access, and compliance with detailed quality requirements. Latin America can benefit from decentralized screening where laboratory access is uneven, although procurement, reimbursement, logistics, and workforce capacity remain important considerations. Europe is influenced by coordinated prevention policies, data-protection expectations, and varied national reimbursement pathways. The Middle East is prioritizing accessible preventive services alongside modernization of healthcare infrastructure. Africa’s opportunities center on community-based screening, affordability, rugged device design, supply reliability, and workforce training. Asia-Pacific combines advanced digital-health ecosystems with large and diverse populations, making local validation, scalable distribution, and integration with public-health programs especially important.

Group Insights: Policy Alignment and Infrastructure Shape Adoption

ASEAN markets may benefit from interoperable, low-complexity solutions that accommodate diverse health systems and urban-rural access gaps. BRICS countries present substantial variation in public-sector capacity, domestic manufacturing, regulatory processes, and disease-prevention priorities, requiring locally adaptable implementation models. The European Union places strong emphasis on medical-device compliance, data protection, cross-border health information, and evidence-based prevention. G7 systems generally have mature clinical infrastructure but demand strong evidence, workflow efficiency, and economic justification. GCC countries can leverage centralized purchasing, digitally enabled care, and preventive-health initiatives while addressing workforce and interoperability requirements. NATO members span different health systems, so shared resilience, secure supply chains, and interoperable data practices are relevant alongside civilian cardiovascular care.

Country Insights: National Systems Determine Use Cases and Evidence Needs

Australia’s dispersed population supports interest in community and remote-care pathways, while Canada’s geography makes decentralized access and connectivity important. Brazil and Mexico may use POC testing to extend screening beyond major urban centers, with procurement and quality consistency requiring attention. China and India combine large prevention needs with varied regional infrastructure, favoring scalable platforms and strong local implementation evidence. France, Germany, Italy, and Spain operate within structured European regulatory and clinical environments, where integration with primary care and reimbursement policy is central. Japan and South Korea have advanced healthcare and technology infrastructures that can support connected testing, provided usability and clinical validation are demonstrated. Russia’s deployment considerations include supply resilience, regulatory alignment, and regional access. The United Kingdom and United States place emphasis on evidence, quality systems, interoperability, and integration into primary care, pharmacy, and chronic-care pathways.

Recommendations for Leaders: Build Trust Before Expanding Deployment

Industry leaders should define specific clinical and operational use cases before selecting devices or software. They should validate analytical performance against laboratory methods, establish quality-control procedures, and train every category of operator. Implementation plans should connect results to documented follow-up, referral, and treatment workflows rather than treating testing as a standalone transaction. Leaders should prioritize open interoperability, privacy-preserving data practices, cybersecurity, and transparent AI governance. Partnership with clinicians, laboratories, pharmacies, public-health authorities, and patient groups can improve adoption and reveal barriers early. Finally, organizations should monitor turnaround time, invalid-result rates, follow-up completion, equity of access, user experience, and clinical outcomes to guide continuous improvement.

Research Methodology: Evidence-Based Assessment of POC Lipid Testing

This executive summary uses a structured qualitative assessment of point-of-care lipid testing across technology, clinical workflow, regulation, access, infrastructure, and digital-health dimensions. Regional, group, and country comparisons are framed around documented health-system characteristics, cardiovascular-prevention priorities, diagnostic access conditions, and implementation requirements. The assessment distinguishes analytical measurement from clinical decision support and treats AI-related observations as capability and governance considerations rather than outcome claims. No market estimates, market sizing, market shares, forecasts, or company-specific information are used.

Conclusion: Reliable Integration Is the Core Advantage

POC lipid testing can strengthen cardiovascular prevention when it delivers dependable results within a complete care pathway. The most durable progress will come from combining validated measurement, trained users, quality oversight, equitable access, interoperable records, and timely clinical action. Regional and national differences mean that deployment models should be adapted to local infrastructure and policy rather than copied uniformly. AI may improve prioritization and coordination, but trust will depend on transparency, safety, and sustained human accountability.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. POC Lipid Testing Market, by Product Type
7.1. Introduction
7.2. Consumables
7.2.1. Controls
7.2.2. Kits
7.2.3. Reagents
7.3. Instruments
7.3.1. Benchtop Analyzers
7.3.2. Handheld Analyzers
8. POC Lipid Testing Market, by Technology
8.1. Introduction
8.2. Chromatographic Methods
8.3. Colorimetric Methods
8.4. Enzymatic Methods
8.5. Immunoassays
9. POC Lipid Testing Market, by Application
9.1. Introduction
9.2. Cvd Risk Assessment
9.3. Diabetes Management
9.4. Preventive Screening
10. POC Lipid Testing Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Diagnostic Labs
10.4. Home Testing
10.5. Hospitals
11. POC Lipid Testing Market, by Distribution Channel
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. E-commerce
11.4. Hospital Pharmacies
11.5. Retail Pharmacies
12. POC Lipid Testing Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. Europe
12.4. North America
12.5. Latin America
12.6. Africa
12.7. Middle East
13. POC Lipid Testing Market, by Group
13.1. Introduction
13.2. NATO
13.3. G7
13.4. BRICS
13.5. European Union
13.6. ASEAN
13.7. GCC
14. POC Lipid Testing Market, by Country
14.1. Introduction
14.2. China
14.3. United States
14.4. Japan
14.5. India
14.6. Germany
14.7. United Kingdom
14.8. Australia
14.9. France
14.10. South Korea
14.11. Italy
14.12. Canada
14.13. Russia
14.14. Brazil
14.15. Mexico
14.16. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. A. Menarini Industrie Farmaceutiche Riunite S.r.l.
16.2. Abaxis, Inc. by Zoetis Inc
16.3. Abbott Laboratories
16.4. Bio-Rad Laboratories, Inc.
16.5. bioMérieux SA
16.6. Callegari Srl
16.7. Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
16.8. Danaher Corporation
16.9. EKF Diagnostics Holdings plc
16.10. F. Hoffmann-La Roche Ltd.
16.11. General Life Biotechnology Co., Ltd.
16.12. Helena Laboratories Corporation
16.13. Nova Biomedical
16.14. Quidel Corporation
16.15. SD Biosensor, Inc.
16.16. Sekisui Medical Co., Ltd.
16.17. Siemens AG
16.18. Sienco, Inc.
16.19. Sinocare Inc.
16.20. Thermo Fisher Scientific Inc.
16.21. Trinity Biotech PLC
16.22. VivaChek Biotech (Hangzhou) Co., Ltd.
16.23. Werfen, S.A.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global POC Lipid Testing Market, Years Considered for the Study
FIGURE 2. Global POC Lipid Testing Market, Research Design
FIGURE 3. Global POC Lipid Testing Market, Research Framework
FIGURE 4. Global POC Lipid Testing Market, Data Triangulation
FIGURE 5. Global POC Lipid Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global POC Lipid Testing Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global POC Lipid Testing Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global POC Lipid Testing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global POC Lipid Testing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global POC Lipid Testing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global POC Lipid Testing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global POC Lipid Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global POC Lipid Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global POC Lipid Testing Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global POC Lipid Testing Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global POC Lipid Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global POC Lipid Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global POC Lipid Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global POC Lipid Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global POC Lipid Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global POC Lipid Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global POC Lipid Testing Market Segmentation & Coverage
TABLE 2. Global POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Benchtop Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Benchtop Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Benchtop Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Handheld Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Handheld Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Handheld Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 26. Global Chromatographic Methods Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Chromatographic Methods Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Chromatographic Methods Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Colorimetric Methods Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Colorimetric Methods Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Colorimetric Methods Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Enzymatic Methods Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Enzymatic Methods Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Enzymatic Methods Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 39. Global Cvd Risk Assessment Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Cvd Risk Assessment Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Cvd Risk Assessment Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Diabetes Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Diabetes Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Diabetes Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Preventive Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Preventive Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Preventive Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 49. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Diagnostic Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Diagnostic Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Diagnostic Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Home Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Home Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Home Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 62. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global E-commerce Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global E-commerce Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global E-commerce Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global POC Lipid Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific POC Lipid Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. Europe POC Lipid Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Europe POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 85. Europe POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 86. Europe POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 87. Europe POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 88. Europe POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Europe POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Europe POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. North America POC Lipid Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. North America POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 93. North America POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 94. North America POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 95. North America POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 96. North America POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. North America POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. North America POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 99. Latin America POC Lipid Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Latin America POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 101. Latin America POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 102. Latin America POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 103. Latin America POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 104. Latin America POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Latin America POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. Latin America POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. Africa POC Lipid Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Africa POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 109. Africa POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 110. Africa POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 111. Africa POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 112. Africa POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Africa POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Africa POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 115. Middle East POC Lipid Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Middle East POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. Middle East POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 118. Middle East POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 119. Middle East POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 120. Middle East POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Middle East POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Middle East POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 123. Global POC Lipid Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. NATO POC Lipid Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. NATO POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. NATO POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 127. NATO POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 128. NATO POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 129. NATO POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. NATO POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. NATO POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 132. G7 POC Lipid Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. G7 POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 134. G7 POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 135. G7 POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 136. G7 POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 137. G7 POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. G7 POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. G7 POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 140. BRICS POC Lipid Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. BRICS POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 142. BRICS POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 143. BRICS POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 144. BRICS POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 145. BRICS POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. BRICS POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. BRICS POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 148. European Union POC Lipid Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. European Union POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 150. European Union POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 151. European Union POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 152. European Union POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 153. European Union POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. European Union POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. European Union POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 156. ASEAN POC Lipid Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. ASEAN POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. ASEAN POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 159. ASEAN POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 160. ASEAN POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 161. ASEAN POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. ASEAN POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. ASEAN POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 164. GCC POC Lipid Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. GCC POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. GCC POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 167. GCC POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 168. GCC POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 169. GCC POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. GCC POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. GCC POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. Global POC Lipid Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. China POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 174. China POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. China POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 176. China POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 177. China POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 178. China POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. China POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. China POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. United States POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 182. United States POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. United States POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 184. United States POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 185. United States POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 186. United States POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. United States POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. United States POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 189. Japan POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 190. Japan POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Japan POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 192. Japan POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 193. Japan POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 194. Japan POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. Japan POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. Japan POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 197. India POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 198. India POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 199. India POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 200. India POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 201. India POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 202. India POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. India POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. India POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 205. Germany POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 206. Germany POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 207. Germany POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 208. Germany POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 209. Germany POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. Germany POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Germany POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Germany POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. United Kingdom POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 214. United Kingdom POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 215. United Kingdom POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 216. United Kingdom POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 217. United Kingdom POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. United Kingdom POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. United Kingdom POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. United Kingdom POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. Australia POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 222. Australia POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 223. Australia POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 224. Australia POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 225. Australia POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 226. Australia POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Australia POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Australia POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 229. France POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 230. France POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 231. France POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 232. France POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 233. France POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 234. France POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. France POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. France POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 237. South Korea POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 238. South Korea POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. South Korea POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 240. South Korea POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 241. South Korea POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 242. South Korea POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. South Korea POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. South Korea POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 245. Italy POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 246. Italy POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 247. Italy POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 248. Italy POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 249. Italy POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 250. Italy POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. Italy POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Italy POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Canada POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 254. Canada POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 255. Canada POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 256. Canada POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 257. Canada POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 258. Canada POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. Canada POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Canada POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 261. Russia POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 262. Russia POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 263. Russia POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 264. Russia POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 265. Russia POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. Russia POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. Russia POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Russia POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 269. Brazil POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 270. Brazil POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 271. Brazil POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 272. Brazil POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 273. Brazil POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 274. Brazil POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Brazil POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. Brazil POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 277. Mexico POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 278. Mexico POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. Mexico POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 280. Mexico POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 281. Mexico POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 282. Mexico POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. Mexico POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. Mexico POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 285. Spain POC Lipid Testing Market Size, 2017-2032 (USD Million)
TABLE 286. Spain POC Lipid Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 287. Spain POC Lipid Testing Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 288. Spain POC Lipid Testing Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 289. Spain POC Lipid Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 290. Spain POC Lipid Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. Spain POC Lipid Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Spain POC Lipid Testing Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 293. Global POC Lipid Testing Market Share, by Key Player, 2025
TABLE 294. Global POC Lipid Testing Market, Key Experts

Companies Mentioned

  • A. Menarini Industrie Farmaceutiche Riunite S.r.l.
  • Abaxis, Inc. by Zoetis Inc
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Callegari Srl
  • Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • General Life Biotechnology Co., Ltd.
  • Helena Laboratories Corporation
  • Nova Biomedical
  • Quidel Corporation
  • SD Biosensor, Inc.
  • Sekisui Medical Co., Ltd.
  • Siemens AG
  • Sienco, Inc.
  • Sinocare Inc.
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • VivaChek Biotech (Hangzhou) Co., Ltd.
  • Werfen, S.A.

Related Topics

Related Reports

POC Lipid Testing - Global Strategic Business Report - Product Image

POC Lipid Testing - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
2025 Global Forecast for Point-Of-Care (Poc) Lipid Test Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Point-Of-Care (Poc) Lipid Test Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Point of Care Lipid Test Market Report 2026 - Product Image

Point of Care Lipid Test Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Point of Care Lipid Test Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights and Forecast 2024-2034 - Product Image

Point of Care Lipid Test Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights and Forecast 2024-2034

  • Report
  • 160 Pages
  • Global
From
Blood Lipid Test Kits Market - Global Forecast 2026-2032 - Product Image

Blood Lipid Test Kits Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From

About the Market

The Point-of-Care (POC) Lipid Test market is a segment of the larger Point-of-Care Diagnostics industry. It is composed of medical devices and tests used to measure the levels of lipids, such as cholesterol and triglycerides, in a patient's blood. These tests are typically used to diagnose and monitor cardiovascular diseases, and are often performed in a doctor's office or at home. POC Lipid Tests are typically more convenient and cost-effective than traditional laboratory tests, and can provide results in minutes. The POC Lipid Test market is driven by the increasing prevalence of cardiovascular diseases, as well as the growing demand for convenient and cost-effective diagnostic solutions. The market is expected to continue to grow in the coming years, as more companies enter the space and develop innovative products. Some of the major players in the POC Lipid Test market include Abbott, Roche, Siemens, Alere, and Biosite. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.